Description: This guideline is an official statement of the American College of Physicians (ACP),
American College of Chest Physicians (ACCP), American Thoracic Society (ATS), and …

Background: Treatment of moderate or severe chronic obstructive pulmonary disease (COPD)
with combinations of inhaled corticosteroids, long-acting β-agonists, and long-acting …

Rationale: Pulmonary rehabilitation (PR) has demonstrated physiological, symptom-reducing,
psychosocial, and health economic benefits for patients with chronic respiratory diseases, …

Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that
is both preventable and treatable. Our understanding of the pathophysiology of this complex …

Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that
is preventable and treatable but unfortunately remains underdiagnosed. The purpose of the …

Study objectives We have previously shown that tiotropium at 18 μg reduces lung hyperinflation
and dyspnea during exercise and improves exercise tolerance in patients with COPD. …

BACKGROUND:COPD is a major cause of morbidity and mortality in the United States as
well as throughout the rest of the world. An exacerbation of COPD (periodic escalations of …

Dyspnea is a cardinal symptom of chronic obstructive pulmonary disease (COPD), and its
severity and magnitude increases as the disease progresses, leading to significant disability …

Rationale: Small studies have suggested that inhaled corticosteroids can suppress systemic
inflammation in chronic obstructive pulmonary disease (COPD). Objectives: To determine …

Pulmonary rehabilitation (PR) participation is the standard of care for patients with chronic
obstructive pulmonary disease (COPD) who remain symptomatic despite bronchodilator …